Pharmaquest
Sale to the RWS Group
Pharmaquest operates in a very niche area of medicine, translating Patient Recorded Outcomes (PRO’s). Patients own assessments play an increasing and vital role in treatment and care development. This is a complex task which follows a strict methodology in order to enable accurate assessment of data from multinational trials.
PharmaQuest is unique in its field, combining the expertise of an outcomes research organisation with the credentials of a translation company and is, therefore, able to follow the entire lifecycle of a PRO project and provide an exceptionally high quality of service.
Its client base was international, consisting of pharmaceutical companies, clinical research organisations and academia.
EvolutionCBS completed a detailed profiling of potential acquirers in the USA, Far East and UK within just 2 months. The preferred bidder was from world leading translation company, RWS Group, a well-established company seeking to grow that part of the business and establish an even stronger foothold into the Medical Translations Sector.